Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-13-013362

Options or other derivatives

  • Chief Executive Officer acquired 8,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LANGECKER PETER · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-02-27 Grant or award : show line 1 in the form Stock Option (Right to Buy) +8,333 8,333 D
Loading xslF345X03/rrd372254.xml…